June 24, 2026 · Form 4 insider transaction
Janku Filip bought 30,000 shares of Monte Rosa Therapeutics, Inc. at $7.56 per share, a transaction worth $226.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2026.